Literature DB >> 26072461

Minimally Invasive Transforaminal Lumbar Interbody Fusion for Spondylolisthesis: Comparison Between Isthmic and Degenerative Spondylolisthesis.

Jong Yeol Kim1, Jeong Yoon Park2, Kyung Hyun Kim1, Sung Uk Kuh1, Dong Kyu Chin1, Keun Su Kim1, Yong Eun Cho1.   

Abstract

INTRODUCTION: Minimally invasive transforaminal lumbar interbody fusion (MIS TLIF) is a common surgical option for degenerative spondylolisthesis (DS). However, its effectiveness for isthmic spondylolisthesis (IS) is still controversial. No current studies have directly compared perioperative and postoperative results including various radiological parameters between IS and DS after MIS TLIF.
PURPOSE: The purpose of this study is to compare the clinical and radiological results between isthmic and degenerative spondylolisthesis after MIS TLIF.
METHODS: This is a retrospective study of 41 patients who underwent MIS TLIF for single-segment, grade 1 or 2 IS (n = 18) and DS (n = 23). The same surgical techniques and procedure were applied to both groups. Perioperative outcomes (operation time, blood loss, hospital stay, complications); clinical outcomes (visual analog scale [VAS], Oswestry Disability Index [ODI]); radiological parameters (disk height, degree of spondylolisthesis, slip angle, lumbar lordosis, segmental lordosis, sacropelvic parameters: pelvic incidence, sacral slope, pelvic tile); and fusion rates using computed tomography scanning were compared between groups at 1 year postoperatively.
RESULTS: There were no significantly different perioperative results between groups. Mean VAS and ODI scores improved significantly postoperatively in both groups but were not significantly different between groups at each follow-up point. Radiological parameters were not significantly different between groups except disk height and degree of spondylolisthesis. The disk heights were increased postoperatively (IS: 6.79-9.22 mm; DS: 8.18-8.97 mm) in both groups, and there were significant differences preoperatively. In addition, disk height restoration was greater for IS than DS (2.43 mm vs. 0.79 mm, P = 0.01). However, postoperative disk heights were not significantly different between groups. The degree of spondylolisthesis was significantly different between groups both preoperatively (16.77% vs. 11.33%, P < 0.01) and postoperatively (9.79% vs. 3.78%, P < 0.01). However, slip reduction was no different between groups (6.97 vs. 7.56%, P = 0.74). Fusion rates were not significantly different between groups.
CONCLUSIONS: MIS TLIF resulted in similar clinical outcomes when used to treat both isthmic and degenerative spondylolisthesis. Although disk height restoration was more effective for IS than DS, other radiological parameters including fusion rate were no different between groups. For both isthmic and degenerative spondylolisthesis, MIS TLIF can be a safe and effective surgical option.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Degenerative spondylolisthesis; Isthmic spondylolisthesis; Minimally invasive surgery

Mesh:

Year:  2015        PMID: 26072461     DOI: 10.1016/j.wneu.2015.06.003

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  14 in total

Review 1.  Minimally invasive techniques for lumbar decompressions and fusions.

Authors:  Ankur S Narain; Fady Y Hijji; Jonathan S Markowitz; Krishna T Kudaravalli; Kelly H Yom; Kern Singh
Journal:  Curr Rev Musculoskelet Med       Date:  2017-12

Review 2.  Clinical outcomes after minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion for treatment of degenerative lumbar disease: a systematic review and meta-analysis.

Authors:  Gun Keorochana; Kitipong Setrkraising; Patarawan Woratanarat; Alisara Arirachakaran; Jatupon Kongtharvonskul
Journal:  Neurosurg Rev       Date:  2016-12-24       Impact factor: 3.042

3.  What Affects Segmental Lordosis of the Surgical Site after Minimally Invasive Transforaminal Lumbar Interbody Fusion?

Authors:  Soo-Heon Kim; Bang Sang Hahn; Jeong-Yoon Park
Journal:  Yonsei Med J       Date:  2022-07       Impact factor: 3.052

4.  Minimally Invasive Transforaminal Lumbar Interbody Fusion: Comparison of Grade I Versus Grade II Isthmic Spondylolisthesis.

Authors:  Dustin H Massel; Benjamin C Mayo; William W Long; Krishna D Modi; Gregory D Lopez; Grant D Shifflett; Bryce A Basques; Philip K Louie; Daniel D Bohl; Fady Y Hijji; Ankur S Narain; Kern Singh
Journal:  Int J Spine Surg       Date:  2020-04-30

5.  Minimally Invasive Transforaminal Lumbar Interbody Fusion: Comparison of Isthmic Versus Degenerative Spondylolisthesis.

Authors:  Dustin H Massel; Benjamin C Mayo; Grant D Shifflett; Daniel D Bohl; Philip K Louie; Bryce A Basques; William W Long; Krishna D Modi; Fady Y Hijji; Ankur S Narain; Kern Singh
Journal:  Int J Spine Surg       Date:  2020-04-30

6.  Minimally Invasive Transforaminal Lumbar Interbody Fusion at L5-S1 through a Unilateral Approach: Technical Feasibility and Outcomes.

Authors:  Won-Suh Choi; Jin-Sung Kim; Kyeong-Sik Ryu; Jung-Woo Hur; Ji-Hoon Seong
Journal:  Biomed Res Int       Date:  2016-06-28       Impact factor: 3.411

Review 7.  Spinal Biologics in Minimally Invasive Lumbar Surgery.

Authors:  Kevin Y Chang; Wellington K Hsu
Journal:  Minim Invasive Surg       Date:  2018-04-05

8.  Defining the MIS-TLIF: A Systematic Review of Techniques and Technologies Used by Surgeons Worldwide.

Authors:  Sara Lener; Christoph Wipplinger; R Nick Hernandez; Ibrahim Hussain; Sertac Kirnaz; Rodrigo Navarro-Ramirez; Franziska Anna Schmidt; Eliana Kim; Roger Härtl
Journal:  Global Spine J       Date:  2020-05-28

9.  Decompression Versus Fusion for Grade I Degenerative Spondylolisthesis: A Meta-Analysis.

Authors:  Scott Koenig; Julio J Jauregui; Mark Shasti; Ehsan Jazini; Eugene Y Koh; Kelley E Banagan; Daniel E Gelb; Steven C Ludwig
Journal:  Global Spine J       Date:  2018-08-13

10.  Total 3D Airo® Navigation for Minimally Invasive Transforaminal Lumbar Interbody Fusion.

Authors:  Xiaofeng Lian; Rodrigo Navarro-Ramirez; Connor Berlin; Ajit Jada; Yu Moriguchi; Qiwei Zhang; Roger Härtl
Journal:  Biomed Res Int       Date:  2016-07-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.